Bioventus Inc.
Health
Performance
6.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Bioventus Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

05.02.2026
Losing steam. Not trending your way right now.
17.01.2026
Trouble brewing. Volatility and pressure rising.
06.01.2026
Respawned at 1 HP. Still fragile, but back in play.
BVS
Bioventus Inc.
8.21
+1.36%
6.1
Sell
Buy
Bioventus Inc.

Bioventus Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Bioventus Inc. do? Business model and key facts

Get the full picture of Bioventus Inc.: what it builds, where it operates, and how it makes money.

Bioventus Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 930

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

shop
Company facts
Robert E. Claypoole
CEO
930
Employees worldwide
shop
Performance
-25.7%
Last 12 months
-57.26%
Last 5 years
shop
Growth
$573,28M
Revenue year
$0
Net income
shop
Valuation
$549,88M
Market Cap
-20.46
Price/Earnings Ratio

Stocks related to Bioventus Inc.

Selected based on industry alignment and relative market positioning.

CTKB
Cytek Biosciences, Inc.
4.50
-8.72%
8.6
Sell
Buy
Cytek Biosciences, Inc.
VREX
Varex Imaging Corporation
13.78
-1.08%
6.1
Sell
Buy
Varex Imaging Corporation
TCMD
Tactile Systems Technology, Inc.
27.21
-1.52%
6.7
Sell
Buy
Tactile Systems Technology, Inc.
ZIMV
ZimVie Inc.
18.99
+0.00%
7.2
Sell
Buy
ZimVie Inc.
PACB
Pacific Biosciences of California, Inc.
1.72
-12.05%
9.7
Sell
Buy
Pacific Biosciences of California, Inc.

Bioventus Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.